Brief: Dimerix Receives Upfront Payment Of $30 Million From Amicus Therapeutics
06/05/2025 02:32
May 6 (Reuters) - Dimerix Ltd DXB.AX: RECEIVED UPFRONT PAYMENT OF US$30 MILLION FROM AMICUS THERAPEUTICS Further company coverage: DXB.AX ((Reuters.Briefs@thomsonreuters.com))
Recent news on Dimerix
See all newsAustralia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region
Brief: Everest Medicine In Agreement With Dimerix To Develop Commercialize DMX-200 In Greater China, South Korea, And Southeast Asia
Brief: Dimerix Seeks Trading Halt
Brief: Dimerix To Conduct Review Of Action3 Statistical Assumptions